BOARDS 

1999

Temporary Advisor to the World Health Organisation (WHO) as member of scientific working group on kinetoplastid drug discovery and development, Heidelberg (Germany), 14-16 October 1999. 

2005

Member of the Editorial Board of the Beilstein Journal of Organic Chemistry, 2005-date.

2006

• Scientific Advisor to the Council for Scientific and Industrial Research (CSIR) Biosciences as a member of the Research Advisory Panel, 2006-2009.
• Co-opted member of the Research Strengthening Group of the UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases, 2006.
• Temporary Advisor to the World Health Organisation as a Member of the UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases Informal Consultation Meeting on Experts to Advise the WHO on the Proposed Helminth (Parasitic Worm) Initiative to enhance Research & Development (R & D) for new products, 23-25 March 2006, University of Tokyo, Japan. 
  

2007

• Temporary Advisor to the World Health Organisation (WHO) as a Member of the UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases Scientific Working Group Follow up Meeting on the Proposed Helminth (Parasitic Worm) Initiative to enhance R & D for new products, 22-24 January 2007, University of Tokyo, Japan. 
• Temporary Advisor to the World Health Organisation as a Member of the UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (TDR) Scientific Working Group at the Informal Consultation on the new TDR Strategy, 16-17 April 2007, Geneva, Switzerland. 
• Member of the Task Force on Helminth Drug Initiative of the World Health Organisation, 1 November 2007-2010. 

2009

• Member of the Medicines for Malaria Venture (MMV) Expert Scientific Advisory Committee (ESAC), 2009-2014.
• Member of the World Health Organisation (WHO) Antimicrobial Resistance Working Group, 2009-2012.
  

2012

• Symposium Chair and Co-Organiser (with John Butera), American Chemical Society (ACS) symposium entitled "Challenges in Phenotypic Whole Cell High Throughput Screening and Medicinal Chemistry Optimisation of Hits; Strategies to Discover Novel Antiparasitic and Antimycobacterial Agents", 243rd ACS National Meeting 25-29 March 2012, San Diego, California, USA.
• Editor-In-Chief of book: Drug Discovery in Africa, eds. Chibale K., Masimirembwa C. and Davies-Coleman, M., Springer: Germany (2012).

2014

• Speaker on University-Industry Collaborations, National Workshop on the Development of the National Research, Science and Technology Programme for Namibia, 24-25 March 2014, Windhoek, Namibia
• Symposium Chair and Co-Organiser, “Neglected Diseases” at the XXIIIrd International Symposium on Medicinal Chemistry (EFMC-ISMC 2014), 7-11 September 2014 in Lisbon, Portugal. 
• Panellist, on panel discussion: “Improving the impact of the best science for the most neglected Diseases” Organised on the occasion of the Swiss Commission for Research Partnerships with Developing Countries (KFPE)’s 20th anniversary event, 25 September 2014, Basel, Switzerland. 
• Editorial Advisory Board member, ACS Infectious Diseases, 2014-date. 
  

2015

Guest Editor, New Developments in Antiinfectives Research for Tropical Infectious Diseases, Symposia-In-Print, Bioorganic & Medicinal Chemistry, 2015. 

2016

• Symposium Co-Chair and Co-Organiser (with Leann Tilley and Philip Rosenthal), Keystone Symposium, Drug Discovery for Parasitic Diseases, 24-29 January 2016, Granlibakken Resort, Tahoe City, California, USA 
• Editorial Advisory Board Member, Journal of Medicinal Chemistry, 2017-2020.
• Expert Advisory Board Member, United Kingdom (UK) Department of Health Global Antimicrobial resistance (AMR) Innovation Fund, 2016-2020.
  

2018

Editorial Advisory Board Member, Accounts of Chemical Research, 2018-date.

2019

• Editor, Annual Reports in Medicinal Chemistry, Medicinal Chemistry Approaches to Tuberculosis and Trypanosomiasis Volumes 52 2019.
• Editor, Annual Reports in Medicinal Chemistry, Medicinal Chemistry Approaches to Malaria and Other Tropical Diseases Volumes 53, 2019.
  

2020

• Advisory Board Member, Chemical Society Reviews, 2020-2022.
• Editorial Advisory Board Member, ACS Medicinal Chemistry Letters, 2020-2022.
  

2021

• Associate Editor, Journal of Medicinal Chemistry, 2021-2022.
• Member of the Advisory Committee, Rethinking Malaria in the Context of COVID–19, convened by Harvard University’s Defeating Malaria: From the Genes to the Globe Initiative, and co-sponsored with the World Health Organisation (WHO), 2021-2022.
• Editorial Advisory Board Member, ACS Bio & Med Chem Au, 2021-date.
  

2022

• International Advisory Board Member, Angewandte Chemie International Edition, 2022-date.
• Symposium Co-Chair and Co-Organiser (with David A. Fidock and Elizabeth A. Ashley), Keystone Symposium, Malaria: Confronting Challenges From Drug Discovery to Treatment, 10-13 April 2022, Beaver Run Resort, Breckenridge, Colorado, USA.
• Editorial Board Member, Cell, 2022-date.
• Member of the Scientific Advisory Panel for the Sir Howard Dalton Centre for Translational Mechanistic Enzymology (AMR discovery translation), University of Warwick, UK, 2022-date.
  

2023

• Editorial Board Member, ACS Pharmacology & Translational Science, 2023-date.
• Editor-In-Chief, ACS Medicinal Chemistry Letters, 2023-date.
• Member of the International Scientific Committee of the of the XXVIII EFMC International Symposium on Medicinal Chemistry (EFMC-ISMC 2024) to be held in Rome, Italy, (September 1 to 5 2024), 2023.
• Member of the International Human Frontier Science Program Organisation (HFSPO) Council of Scientists, representing South Africa, 2023-date.